Metraipolis › archive › dc_f175e4fed9ed

Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41178590
DOI
10.1080/07853890.2025.2581812
License (as archived)
solo-consultazione
Archived
2026-11-08T19:50:17.624Z
SHA-256 of the archived text
40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2
Stable URL of this page
https://metraipolis.com/documento/dc_f175e4fed9ed

How to cite

Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590 — Europe PMC (en), https://europepmc.org/article/MED/41178590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f175e4fed9ed (Metraipolis archive dc_f175e4fed9ed, sha256 40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2)
BibTeX
@misc{dcf175e4fed9ed,
  title = {Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41178590},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f175e4fed9ed; sha256 40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41178590. Agents can read the archived copy with the MCP tool read_document.